Phathom Pharmaceuticals, Inc. (PHAT) Revenue History
Phathom Pharmaceuticals, Inc. (PHAT) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | $682.00K |
| 2024-12-31 | $55.25M |
| 2025-12-31 | $175.11M |
How PHAT compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc. | $172.35M |
| HRTX | Heron Therapeutics Inc. | $154.90M |
| STIM | Neuronetics Inc. | $149.16M |
| QTRX | Quanterix Corporation | $138.90M |
| NRC | National Research Corporation | $137.39M |
These are five companies in the same sector as PHAT with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Phathom Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("PHAT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PHAT | $9.18 | +0.11% | 1.21M |
| 3 | ||||
| 4 | ||||
| 5 |